Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group - The Lancet Oncology
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS) | Annals of Hematology
How I treat high-risk multiple myeloma - ScienceDirect
Clinical Trials in R/R Multiple Myeloma
Multiple myeloma treatment and management in the elderly. | Semantic Scholar
Multiple myeloma | Nature Reviews Disease Primers
Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma
Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost | International Journal of Hematology
Extramedullary multiple myeloma | Leukemia
Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts and Factors
Carfilzomib in multiple myeloma | PPT
Current Oncology | Free Full-Text | Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse
ASPIRE Trial - KRd VS Rd - Multiple Myeloma Clinical Trials
Dr Lakshya Goyal on LinkedIn: People with advanced multiple myeloma, the second most common blood…
Healthcare reality of the treatment of the high-risk multiple myeloma in Spain | Medicina Clínica (English Edition)
Cardiovascular Complications of Novel Multiple Myeloma Treatments | Circulation
Frontiers | Therapeutic strategies to enhance immune response induced by multiple myeloma cells
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial - The Lancet Oncology
Emerging immunotherapies in multiple myeloma | The BMJ
Carfilzomib in multiple myeloma | PPT
Multiple myeloma | Nature Reviews Disease Primers
Multiple #Myeloma is a... - Dr. Reddy's Laboratories Ltd. | Facebook
Patient characteristics of 130 relapse and refractory multiple myeloma... | Download Scientific Diagram
Kyprolis® Treatment for Patients With Multiple Myeloma - CancerConnect
